SCHEMBL7496572

SCHEMBL7496572

COC(=O)c1ncoc1Cc1ccc(F)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.43
KDM5B Q9UGL1 1/20 0.43
PTGIR P43119 7/20 0.41
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
SCD O00767 1/20 0.38
CDK2 P24941 2/20 0.37
GSK3B P49841 2/20 0.37
METAP2 P50579 1/20 0.37
CNR1 P21554 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
VNN1 O95497 1/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9684703 0.80 PTGIR (0.43) PTGIRGSK3BHTT
SCHEMBL11317135 0.80 PTGIR (0.48) PTGIRGSK3B
SCHEMBL1150853 0.77 CYP4F2 (0.41) KDM5AKDM5BPTGIRKDM4EALDH1A1
SCHEMBL8135631 0.75 GSK3B (0.51) CDK2GSK3BKDM4EGAA
SCHEMBL5548056 0.73 GAA (0.48) KDM5AKDM5BMAOAMAOBSCD
SCHEMBL823438 0.73 ALDH1A1 (0.46) PTGIRKDM4EALDH1A1MAPTHPGD
SCHEMBL21384222 0.72 MAPK1 (0.49) KDM5AKDM5BMAOAMAOBSCD
SCHEMBL28898122 0.72 LOXL2 (0.53) KDM5AKDM5BMAOAMAOBMETAP2
SCHEMBL4768685 0.71 MAPK10 (0.42) KDM4EALDH1A1GAAALOX15TSHR
SCHEMBL5547391 0.71 LMNA (0.41) KDM5AKDM5BKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140906-A4 IMIDAZOLONES AND THEIR USE IN TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER DISORDERS SYNAPTIC PHARMA CORP (US) 2002-03-13 EP disclosed
EP-1140906-A1 IMIDAZOLONES AND THEIR USE IN TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER DISORDERS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2001-10-10 EP disclosed
WO-2000035907-A1 IMIDAZOLONES AND THEIR USE IN TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER DISORDERS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-06-22 WO disclosed
US-6046331-A Imidazolones and their use in treating benign prostatic hyperplasia and other disorders SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-04-04 US disclosed